Ligence Reflecting on RSNA 2023: Key Insights

In a bold stride towards innovation, we are excited to announce the latest enhancements to our flagship product, the Ligence Heart web app software. Through meticulous development and optimization, we’ve taken this cutting-edge application to new heights, ensuring a seamless user experience while harnessing the power of artificial intelligence.

Unlocking the Power of Ligence Heart Web App: A New Era of Efficiency and Functionality

empowering-ai-functionalities

In a bold stride towards innovation, we are excited to announce the latest enhancements to our flagship product, the Ligence Heart web app software. Through meticulous development and optimization, we’ve taken this cutting-edge application to new heights, ensuring a seamless user experience while harnessing the power of artificial intelligence.

Webinar on AI in Echocardiography

webinar-on-ai-in-echocardiography

The course covers several topics related to AI in echocardiography, including successful examples, clinical benefits, and the current state of AI in stress echocardiography. The event also features a presentation on AI in pediatric settings, including hands-on experience and future plans.

The webinar was held by highly respected experts in the field, including Prof. Dr. Partho Sengupta, Dr. Sandeep Hothi, Dr. Arnas Karuzas, and Dr. Corina Vasile.

A Reflective Journey Through a Year of Landmark Moments with Ligence

radiological-society-of-north-america-rsna-2022-a-glowing-presence-2

As the pages of the past year turn, we find ourselves immersed in a tapestry of extraordinary accomplishments that have shaped Ligence’s trajectory. Each milestone is a testament to our unwavering dedication, a reminder of the strides we’ve made in reshaping healthcare through innovation. Join us on this introspective voyage, as we retrace the path of our notable achievements in the precise order they unfolded.

Aortic stenosis

aortic-stenosis

Aortic stenosis (AS) is one of the most common acquired heart defects in adults. Echocardiography is a primary diagnostic tool to assess the severity of this pathology. The assessment of aortic stenosis requires complex measurements that take considerable amount of time and should be performed by an expe

Motivational interview?

motivational-interview

Is motivational interview a clinical tool?

Yes!

It’s not a job interview, neither it’s a coaching session. It’s a technique to prompt a change in patient’s lifestyle that physicians and nurses could/should use it in their cabinets. Much of health care today involves helping patients manage conditions whose outcomes can be greatly influenced by lifestyle or behaviour change. Motivational interview (MI) is a powerful tool to enhance communication with patients and guide them in making choices to improve their health, from weight loss, exercise, and smoking cessation, to medication adherence. Its effectiveness has been proven by numerous research. MI can last from 15 to 160 minutes, depending on the setting.

Ligence receives Certificate for the Ligence Heart AI system

No-pic-blog-small

Ligence Heart analysis and reporting system for transthoracic echocardiography has been certified under MDR 2017/745.

The device is regulated as medical device class IIa under the framework of the European Commission.

The Ligence Heart AI system will be now offered to care centres in Europe to aid with the burdens of the echocardiography procedure.

The company expects first sales to happen in Lithuania and the Baltic region, followed by the Netherlands.

Webinar Digital Cardiology

webinar-digital-cardiology

A moment from a joint webinar “Digital Cardiology” organised by the Lithuanian Cardiology Society and Ligence.

The star guest Eugenio Picano delivered a presentation on what do clinicians want from AI in echocardiography. One of the main missions of AI in echocardiography is to leverage the “hibernating data” from retrospective databases which may open new insights in patient outcomes.

Make sure to follow updates from Lithuanian Cardiology Society and Ligence.